Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2015, Article ID 603402, 3 pages
http://dx.doi.org/10.1155/2015/603402
Case Report

Refractory Epistaxis due to Severe Factor V Deficiency with Inhibitor

1Department of Medicine, Robert Wood Johnson Medical School, 125 Paterson Street, New Brunswick, NJ 08901, USA
2University of Central Florida, 4000 Central Florida Boulevard, Orlando, FL 32816, USA
3Division of Hematology and Oncology, University of Florida Health Cancer Center in Orlando, 1400 S Orange Avenue, MP700, Orlando, FL 32806, USA

Received 10 June 2015; Accepted 29 July 2015

Academic Editor: Kate Khair

Copyright © 2015 Elizabeth S. John et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Kruse-Jarres and C. Leissinger, “Acquired coagulation disorders caused by inhibitors,” in Consultative Hemostasis and Thrombosis, pp. 79–87, Elsevier, 3rd edition, 2013. View at Google Scholar
  2. M. Ashizawa, S.-I. Kimura, H. Wada et al., “Acquired factor V inhibitor associated with life-threatening bleeding and a mixing test result that indicated coagulation factor deficiency,” Hematology, vol. 18, no. 5, pp. 300–304, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Franchini and G. Lippi, “Acquired factor V inhibitors: a systematic review,” Journal of Thrombosis and Thrombolysis, vol. 31, no. 4, pp. 449–457, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Duckers, P. Simioni, L. Spiezia et al., “Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency,” Blood, vol. 112, no. 9, pp. 3615–3623, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Krieg, J.-D. Studt, I. Sulzer, B. Lämmle, and J. A. Kremer Hovinga, “Is factor V Leiden a risk factor for thrombotic microangiopathies without severe ADAMTS13 deficiency?” Thrombosis and Haemostasis, vol. 94, no. 6, pp. 1186–1189, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. L. A. Ai, P. Kuperan, H. N. Chin, and J. N. Heng, “Acquired factor V inhibitor. A problem-based systematic review,” Thrombosis and Haemostasis, vol. 101, no. 5, pp. 852–859, 2009. View at Publisher · View at Google Scholar · View at Scopus